Residual paralysis: A real problem or did we invent a new disease?

Canadian Journal of Anesthesia

Volumn 60, Issue 7, 2013, Pages 714-729

  Donati, François ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; ATROPINE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; GLYCOPYRRONIUM BROMIDE; LONG ACTING DRUG; MIVACURIUM; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; VECURONIUM;

ADDUCTOR POLLICIS MUSCLE; AIRWAY OBSTRUCTION; ANALYTICAL PARAMETERS; ANESTHESIST; ANESTHETIC RECOVERY; ARTICLE; CARDIOTOXICITY; CORRUGATOR SUPERCILII MUSCLE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DYSPHAGIA; EXTRAOCULAR MUSCLE; GASTROINTESTINAL TOXICITY; HAND MUSCLE; HEALTH SURVEY; HUMAN; INCIDENCE; LUNG TOXICITY; MEDICAL DECISION MAKING; NEUROMUSCULAR BLOCKING; PARALYSIS; PATIENT MONITORING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROBABILITY; PROTHROMBIN TIME; PULMONARY ASPIRATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; RECOVERY ROOM; RESIDUAL PARALYSIS; SIDE EFFECT; TRAIN OF FOUR RATIO;

ANESTHESIA RECOVERY PERIOD; CHOLINESTERASE INHIBITORS; GAMMA-CYCLODEXTRINS; HUMANS; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR MONITORING; POSTOPERATIVE COMPLICATIONS; RESPIRATORY PARALYSIS;

EID: 84879130915     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-013-9932-8     Document Type: Article

References (35)

1. Viby-Mogensen J, Jorgensen BC, Ording H. Residual curarization in the recovery room. Anesthesiology 1979; 50: 539-41.
2. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98: 302-16.
3. Plaud B, Debeane B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-22.
4. Murphy GS, Brull SJ. Residual neuromuscular block: Lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of neuromuscular block. Anesth Analg 2010; 111: 120-8.
5. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-9.
6. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology 1990; 73: 870-5.
7. Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Resp Crit Care Med 2007; 175: 9-15.
8. Heier T, Caldwell JE, Feiner JR, Lui L, Ward T, Wright PM. Relationship between normalized adductor pollicis train-of-four ration and manifestations of residual neuromuscular block: a study using acceleromyography during near steady-state concentrations of mivacurium. Anesthesiology 2010; 113: 825-32.
9. Eikermann M, Groeben H, Husing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-7.
10. Kumar GV, Nair AP, Murthy HS, Jalaja KR, Ramachandra K, Parameshwara G. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology 2012; 117: 1234-44.
11. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107: 130-7.
12. Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effects of tubocurarine on indirect elicited train-of-four muscle responses and respiratory measurements in humans. Br J Anaesth 1975; 47: 570-4.
13. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43.
14. Asai T, Koga K, Vaughan RS. Respiratory complications associated with tracheal intubation. Br J Anaesth 1998; 80: 767-75.
15. Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-54.
16. Butterly A, Bittner EA, George E, et al. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth 2010; 105: 304-9.
17. Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389-98.
18. Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345: e6329.
19. Brull S, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111: 129-40.
20. Plaud B, Debaene B, Donati F. The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Anesthesiology 2001; 95: 96-101.
21. Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology 2012; 117: 964-72.
22. Capron F, Fortier LP, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg 2006; 102: 1578-84.
23. Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice: a systematic review of the evidence. Anesthesiology 2008; 108: 1117-40.
24. McCourt KC, Mirakhur RK, Kerr CM. Dosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recovery. Anaesthesia 1999; 54: 651-5.
25. Morita T, Kurosaki D, Tsukagoshi H, Shimada H, Sato H, Goto F. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia. Anaesthesia 1997; 52: 538-43.
26. Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg 1999; 89: 333-9.
27. Tramer MR, Fuchs-Buder T. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth 1999; 82: 379-86.
28. Cheng CR, Sessler DI, Apfel CC. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting? Anesth Analg 2005; 101: 1349-55.
29. Caldwell JE. Clinical limitations of acetylcholinesterase antagonists. J Crit Care 2009; 24: 21-8.
30. Eikermann M, Fassbender P, Malhotra A, et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 2007; 107: 621-9.
31. Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology 2010; 112: 34-40.
32. Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular blockade: a systematic review and economic evaluation. Br J Anaesth 2010; 105: 558-67.
33. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217-9.
34. McDonnell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106: 199-201.
35. Cammu GV, Smet V, De Jongh K, Vandeput D. A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery. Anaesth Intensive Care 2012; 40: 999-1006.